FrancophonIA/ELRC3.0 huggingface dataset:
English: It is given in combination with melphalan and prednisone (other medicines for multiple myeloma) to patients who have not been treated before and who are not suitable for high-dose chemotherapy with a bone marrow transplant.
Maltese: Jingħata f'kombinazzjoni ma' melphalan u prednisone (mediċini oħra għallmajeloma multipla) lil pazjenti li ma jkunux irċievew kura qabel u li ma jkunux adattati għal kimoterapija b'doża għolja li jkollhom trapjant tal-mudullun.
English: Velcade is a medicine given by injection that contains the active substance bortezomib.
Maltese: Velcade hija mediċina li tingħata permezz ta' injezzjoni li fiha s-sustanza attiva bortezomib.
English: What is happening with Velcade for the treatment of multiple myeloma?
Maltese: X'inhu jiġri b'Velcade għall-kura ta' majeloma multipla?
English: Based on the review of the data and the company's response to the CHMP's questions, at the time of the withdrawal the CHMP had some concerns and was of the provisional opinion that Velcade could not have been approved for the treatment of patients with relapsed follicular non-Hodgkin lymphoma.
Maltese: Fuq il-bażi tar-reviżjoni tad-dejta u t-tweġibiet tal-kumpanija għal-lista ta' mistoqsijiet tas-CHMP, fiżżmien tal-irtirar, is-CHMP kellu xi tħassib u kien tal-idea provviżorja li Velcade ma setax jiġi approvat għall-kura ta' pazjenti bil-limfoma follikulari mhux ta' Hodgkin li tkun irkadiet.
English: EU/2/17/217/001-002
Maltese: FIS-SUQ EU/2/17/217/001-002
English: Date of first authorisation: 06/11/2017.
Maltese: DATA TAL-EWWEL AWTORIZZAZZJONI / TIĠDID TAL-AWTORIZZAZZJONI Data tal-ewwel awtorizzazzjoni : 06/11/2017.
English: 102 µg FeLV
Maltese: 102 µg FeLV antiġen
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reactions) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Maltese: Il-frekwenza ta' effetti mhux mixtieqa hija definita skont din il-konvenzjoni: - komuni ħafna (aktar minn wieħed f'10 annimali kkurati li juru effetti mhux mixtieqa matul ilperjodu ta' kura waħda) - komuni (aktar minn wieħed iżda inqas minn 10 annimali ikkurat f'100 annimal) - mhux komuni (aktar minn wieħed iżda inqas minn10 annimali ikkurat f'1,000 annimal) - rari (aktar minn wieħed iżda inqas minn10 annimali f'10,000 annimal ikkurat) - rari ħafna (inqas minn annimal wieħed f'10,000 annimal ikkurat, inklużi rapporti iżolati).
English: Store and transport refrigerated (2 C - 8 C).
Maltese: Aħżen u ttrasporta ġo friġġ (2 °C - 8 °C).
English: C/Josefa Valcárcel n°38 28027 Madrid, Spain
Maltese: MSD Animal Health, S.L. C/Josefa Valcárcel n°38 28027 Madrid, Spain
English: ère avenue 2065 m LID 06516 Carros France
Maltese: ère avenue 2065 m LID 06516 Carros Franza
English: Suspension for injection.
Maltese: Suspensjoni għal injezzjoni.
English: Adjuvants: 3% aluminium hydroxide gel expressed as mg Al3+
Maltese: Adjuvanti: 3 % ġel idrossidu tal-aluminjum rappreżentat bħala mg Al3+
English: Sodium chloride Disodium phosphate anhydrous Potassium dihydrogen phosphate Aluminium hydroxide gel Quillaja saponaria Water for injections
Maltese: Klorur tas-sodju Fosfat anidru tad-dissodju Fosfat di-idroġenu tal-potassju Ġell idrossidu tal-aluminju Kwillaja saponarja
English: Opalescent liquid.
Maltese: Likwidu opalexxenti.
English: Adjuvants: 3% aluminium hydroxide gel expressed as mg Al
Maltese: Adjuvanti: 3% ġel idrossidu tal-aluminjum rappreżentat bħala mg Al
English: Active substance: Minimum quantity of purified p45 FeLV-envelope antigen 102 µg
Maltese: Kwantità minima tal-antiġen p 45FeLV-envelop ippurifikat 102 µg
English: Plastic or cardboard box of 50 vials.
Maltese: Kaxxa tal-plastik jew tal-kartun ta' 50 kunjetti.
English: Excipients: Buffered isotonic solution to 1 ml.
Maltese: Soluzzjoni isotonika newtralizzata sa millilitru
English: 1ère avenue 2065 m LID 06516 Carros France
Maltese: 1ère avenue 2065 m L.I.D., 06516 Carros
English: Excipients: Buffered isotonic solution to
Maltese: Soluzzjoni isotonika newtralizzata sa
English: Active substance: Minimum quantity of purified p45 FeLV-envelope antigen
Maltese: Kwantità minima ta' antiġen p 45FeLV-envelop ippurifikat
English: België/Belgique/Belgien INTERVET INTERNATIONAL BV Wim de Körverstraat 35, P.O.
Maltese: België/Belgique/Belgien INTERVET INTERNATIONAL BV Wim de Körverstraat 35, P.O. Box 50
English: Nobivac LeuFel suspension for injection for cats
Maltese: VETERINARJU Nobivac LeuFel Suspensjoni għal injezzjoni għall-qtates
English: Box of 10 or 50 vials
Maltese: KAXXA TA' 10 JEW 50
English: Luxembourg/Luxemburg INTERVET INTERNATIONAL BV Wim de Körverstraat 35, P.O.
Maltese: Luxembourg/Luxemburg INTERVET INTERNATIONAL BV Wim de Körverstraat 35, P.O. Box 50
English: Incompatibilities: Do not mix with any other veterinary medicinal products except FELIGEN RCP or FELIGEN CRP.
Maltese: Inkompatibilitajiet Tħallatx ma' ebda prodott mediċinali veterinarju ieħor ħlief ma' FELIGEN CRP jew FELIGEN RCP.
English: Subcutaneous use
Maltese: Sustanzi attivi
English: STATEMENT OF ACTIVE SUBSTANCES
Maltese: Sustanza attiva:
English: Slovenská republika INTERVET INTERNATIONAL BV Wim de Körverstraat 35, P.O.
Maltese: Slovenská republika INTERVET INTERNATIONAL BV Wim de Körverstraat 35, P.O. Box 50
English: Република България INTERVET INTERNATIONAL BV Wim de Körverstraat 35, P.O.
Maltese: Република България INTERVET INTERNATIONAL BV Wim de Körverstraat 35, P.O. Box 50
English: Type I glass vials containing one dose (1 ml) of the vaccine closed with a 13 mm-diameter butyl elastomer stopper and aluminium capsule.
Maltese: Kunjett tal-ħġieg tat-tip I li fih doża waħda tal-prodott mediċinali veterinarju (1 ml), magħluq b'tapp tal-lastku tal-butil b'dijametru ta' 13mm u kapsula tal-aluminjum.
English: Do not mix with any other veterinary medicinal products except FELIGEN RCP or FELIGEN CRP.
Maltese: Tħallatx ma' ebda prodott mediċinali veterinarju ieħor ħlief ma' FELIGEN CRP jew FELIGEN RCP.
English: Protection against persistent viraemia is observed in 73% of cats 3 weeks after their first vaccine injection.
Maltese: Protezzjoni kontra l-viraemija persistenti hija osservata fi 73% tal-qtates tliet ġimgħat wara l-ewwel injezzjoni bil-vaċċin.
English: Vaccine against feline leukaemia.
Maltese: Użu taħt il-ġilda.
English: PSUR submissions for Nobivac LeuFel shall be synchronised and submitted at the same frequency as for LEUCOGEN.
Maltese: Il-PSURs għal Nobivac LeuFel għandhom tkun sinkronizzati u jiġu sottomessi bl-istess frekwenza għal ta' LEUCOGEN.
English: Safety and efficacy data are available which demonstrate that this vaccine can be mixed and administered with FELIGEN CRP or FELIGEN RCP.
Maltese: Hemm informazzjoni dwar is-sigurtà u l-effikaċja li turi li dan il-vaċċin jista' jitħallat u jiġi amministrat ma' FELIGEN CRP jew FELIGEN RCP.
English: 20 January 2011
Maltese: 20 ta' Jannar 2011
English: Zometa has been authorised since March 2001.
Maltese: Zometa ilu awtorizzat minn Marzu 2001.
English: Zoledronic acid, the active substance in Zometa, blocks an enzyme called ‘farnesyl pyrophosphate synthase'.
Maltese: Zoledronic acid, is-sustanza attiva f'Zometa, jimblokka enzima li tissejjaħ ‘farnesyl pyrophosphate synthase'.
English: Zometa is a medicine that contains the active substance zoledronic acid.
Maltese: Zometa huwa mediċina li fiha s-sustanza attiva zoledronic acid.
English: The full European Public Assessment Report for Zometa can be found on the Agency's website ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Maltese: Ir-Rapport Pubbliku Ewropew ta' Valutazzjoni sħiħ għal Zometa jista' jinstab fis-sit tal-Aġenzija ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: How far into the evaluation was the application when it was withdrawn?
Maltese: Sa fejn kienet waslet l-evalwazzjoni tal-investigazzjoni qabel ma din ġiet irtirata?
English: The study included 1,803 women previously treated with surgery who received Zometa every six months for three years, and were followed up for five years.
Maltese: Dan l-istudju sar fuq total ta' 1,803 nisa li kienu ħadu kura qabel permezz ta' kirurġija, li rċevew Zometa kull sitt xhur għal tliet snin, u ġew segwiti għal ħames snin.
English: What is happening with Zometa for the prevention of bone events in cancer patients?
Maltese: X'qed jiġri b'Zometa għall-prevenzjoni ta' episodji fl-għadam fil-pazjenti bil-kanċer?
English: On 14 December 2010, Novartis Europharm Limited officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a new indication for Zometa, in the treatment of early breast cancer in premenopausal women.
Maltese: Fl-14 ta' Diċembru 2010, Novartis Europharm Limited għarraf uffiċjalment lill-Kumitat għall-Prodotti Mediċinali għall-Użu mill-Bniedem (CHMP) bl-intenzjoni li jirtira l-applikazzjoni tiegħu għal indikazzjoni ġdida għal Zometa, fil-kura tal-kanċer tas-sider fi stadju bikri f'nisa li għadhom mhumiex fil-fażi talmenopawża.
English: What was Zometa expected to be used for?
Maltese: Għalxiex kien mistenni li jintuża Zometa?
English: This means that the CHMP had evaluated the documentation provided by the company and formulated a list of questions.
Maltese: Dan ifisser li s-CHMP kien evalwa d-dokumentazzjoni pprovduta mill-kumpanija u fassal lista ta' mistoqsijiet.
English: All women also received goserelin, a medicine that suppresses the activity of the ovaries.
Maltese: In-nisa kollha wkoll irċevew goserelin, mediċina li twaqqaf l-attività tal-ovarji.
English: Early breast cancer is breast cancer that has not spread and has been treated by surgery.
Maltese: Il-kanċer tas-sider fi stadju bikri huwa kanċer tas-sider li għadu ma nfirixx u li ġie kkurat permezz ta' kirurġija.
English: Zometa was only to be used if the breast cancer was ‘hormone receptor positive' (the cancer is likely to respond to hormonal treatment), and in combination with hormonal treatment.
Maltese: Zometa kellu jintuża biss jekk il-kanċer tas-sider kien ‘pożittiv għar-riċettur tal-ormoni' (huwa probabbli li l-kanċer jirrispondi għallkura bl-ormoni), u f'kombinazzjoni ma' kura bl-ormoni.
English: The study compared anastrozole and tamoxifen (medicines used in hormone-receptor positive breast cancer) with or without Zometa.
Maltese: L-istudju qabbel anastrozole u tamoxifen (mediċini użati fil-kanċer tas-sider pożittiv għar-riċettur tal-ormoni) bi jew mingħajr Zometa.
English: How is Zometa expected to work?
Maltese: Kif huwa mistenni li jaħdem Zometa?
English: Based on the review of the data and the company's responses to the CHMP list of questions, at the time of the withdrawal, the CHMP had some concerns and was of the provisional opinion that Zometa could not have been approved for the adjuvant treatment of early breast cancer.
Maltese: Għalhekk, fiż-żmien tal-irtirar, is-CHMP kien tal-opinjoni li fuq il-bażi tad-dejta ppreżentata millkumpanija, il-mediċina ma setgħetx tiġi approvata.
English: Zometa can also be used to treat hypercalcaemia (high levels of calcium in the blood) caused by tumours.
Maltese: Zometa jista' jintuża wkoll fil-kura ta' iperkalċemija (livelli għolja ta' kalċju fid-demm) kkaġunat mit-tumuri.
English: Communication
Maltese: Komunikazzjoni
English: • The MAHs should conduct a pre-clinical study on identification of reactive metabolites and protein adduct information.
Maltese: • Id-Detenturi tal-Awtorizzazzjoni għat-Tqegħid fis-Suq għandhom jagħmlu studju prekliniku dwar l-identifikazzjoni ta' metaboliti reattivi u informazzjoni li tirrigwarda l-proteini.
English: • The MAHs should inform healthcare professionals on the outcome of this review on nimesulide via a “Direct Healthcare Professional Communication” (DHPC) to be agreed with the CHMP.
Maltese: • Id-Detenturi tal-Awtorizzazzjoni għat-Tqegħid fis-Suq għandhom jinfurmaw lill-professjonisti fil-qasam tas-saħħa fuq l-eżitu ta' din ir-reviżjoni dwar nimesulide via “Komunikazzjoni Professjonali Diretta fil-Qasam tas-Saħħa” (Direct Healthcare Professional Communication (DHPC)) sabiex isir qbil mas-CHMP.
English: Post-marketing surveillance
Maltese: Studji u Reviżjonijiet
English: ANNEX IV CONDITIONS OF THE MARKETING AUTHORISATIONS
Maltese: ANNESS IV KUNDIZZJONIJIET TAL-AWTORIZZAZZJONIJIET GĦAT-TQEGĦID FIS-SUQ
English: The protocol should be submitted to the CHMP by 3 months after the completion of the final study report of the retrospective study for review and agreement.
Maltese: Il-protokoll għandu jiġi sottomess lis-CHMP mhux iktar tard minn 3 xhur wara t-tlestija tar-rapport finali ta' studju fuq l-istudju retrospettiv għarreviżjoni u l-ftehim.
English: The final study reports of the above studies should be submitted to the National Competent Authorities for assessment.
Maltese: Ir-rapporti ta' studju finali tal-istudji msemmija għandhom jiġu sottomessi lill-Awtoritajiet Kompetenti Nazzjonali għal valutazzjoni.
English: The following conditions in relation to post-marketing surveillance, studies and review and communication shall be fulfilled by the Marketing Authorisation Holders of nimesulide containing medicinal products (systemic formulation).
Maltese: Rigward il-kondizzjonijiet li ġejjin għal dak li jirrigwarda s-sorveljanza ta' wara t-tqegħid fis-suq, listudji u r-reviżjonijiet u l-komunikazzjoni għandhom isiru kollha mid-Detenturi tal-Awtorizzazzjoni għat-Tqegħid fis-Suq ta' nimesulide li jkun fiha l-prodotti mediċinali (fomulazzjoni sistematika).
English: A report should be provided to the National Competent authorities for assessment every 6 months as part of the PSUR (starting within one semester after adoption of the Commission Decision).
Maltese: xhur għandu jitressaq rapport mill-Awtoritajiet Nazzjonali Kompetenti għall-valutazzjoni bħala parti mill-PSUR (li jibda semestru wara l-adozzjoni tad-Deċiżjoni tal-Kummissjoni).
English: • The MAHs should conduct a review of epidemiological data to review the risk of hepatic damage from nimesulide in comparison with other NSAIDs
Maltese: • Id-Detenturi tal-Awtorizzazzjoni għat-Tqegħid fis-Suq għandhom jagħmlu reviżjoni tad-dejta epidemjoloġika sabiex jirrevedu r-riskju ta' ħsara epatika minn nimesulide meta mqabbla ma' NSAIDs oħra.
English: The MAHs should strengthen the medical review, refine the monitoring of reporting rates, and improve the quality of Individual Case Safety Reports of nimesulide.
Maltese: Id-Detenturi tal-Awtorizzazzjoni għat-Tqegħid fis-Suq għandhom isaħħu r-reviżjoni medika, itejbu lmonitoraġġ tar-rati ta' rappurtar u jtejbu l-kwalità tar-Rapporti ta' Sigurtà tal-Każijiet Individwali ta' nimesulide.
English: The communication shall include comprehensive information on the safety risks associated with the use of nimesulide.
Maltese: Il-komunikazzjoni għandha tinkludi informazzjoni sħiħa fuq ir-riskji tas-sigurtà assoċjati mal-użu ta' nimesulide.
English: • The MAHs should perform a survey to clarify the modes of use of nimesulide in selected EU Member States to identify potential misuse.
Maltese: • Id-Detenturi tal-Awtorizzazzjoni għat-Tqegħid fis-Suq għandhom jagħmlu stħarriġ sabiex jiċċaraw l-iskopijiet tal-użu ta' nimesulide f'ċerti Stati Membri tal-UE u jidentifikaw xi użu potenzjalment ħażin.
English: These PSURs should be submitted to the National Competent Authorities for assessment.
Maltese: Dawn il-PSURs għandhom jiġu sottomessi lill-Awtoritajiet Kompetenti Nazzjonali għal valutazzjoni.
English: This retrospective study should lead to a follow-up prospective study in transplant centres.
Maltese: Dan l-istudju retrospettiv għandu jwassal għal studju prospettiv ta' kontinwazzjoni fiċ-ċentri ta' trapjant.
English: • The MAHs should submit a revised Risk Management Plan for nimesulide, considering the comments raised during this procedure, to the CHMP.
Maltese: • Id-Detenturi tal-Awtorizzazzjoni għat-Tqegħid fis-Suq għandhom jissottomettu Pjan Rivedut għall-Ġestjoni tar-Riskju għal nimesulide lis-CHMP, u fih jikkonsidraw il-punti li tqajmu matulil-proċedura.
English: • The MAHs should perform a monitoring activity to evaluate the effectiveness of risk communication on nimesulide.
Maltese: • Id-Detenturi tal-Awtorizzazzjoni għat-Tqegħid fis-Suq għandhom jagħmlu attività ta' sorveljanza sabiex jevalwaw l-effikaċja tal-komunikazzjoni tar-riskju ta' nimesulide.
English: The MAHs should expedite and submit all safety reports and case series in PSURs for nimesulide, with a six monthly periodicity.
Maltese: Irreazzjonijiet epatiċi għandhom jingħataw b'mod kumulattiv u għall-perjodu kopert mill-PSUR.
English: This study should address the relative risk of nimesulide in respect to other NSAIDs to cause severe hepatic reactions leading to transplants.
Maltese: Dan l-istudju għandu jindirizza r-riskju relattiv ta' nimesulide meta pparagunat ma' NSAIDs oħra fl-ikkawżar ta' reazzjonijiet epatiċi li jwasslu għal trapjanti.
English: EU Number
Maltese: Numru tal-UE Isem Qawwa Għamla
English: Medicinal product no longer authorised
Maltese: Prodott m ediċinali li m'għadux awtorizzat
English: ETHYPHARM 17/21 rue Saint-Matthieu 78550 Houdan
Maltese: L-ISMIJIET, GĦAMLA FARMAĊEWTIKA (GĦAMLIET
English: ANNEX I LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES
Maltese: TAL-PRODOTT(I) MEDIĊINALI, MNEJN JINGĦATA, LAPPLIKANT(I), ID-DETENTUR(I) TA`
English: 1 ml (120 mg/ml) 1 pre-filled pen + 2 alcohol pads
Maltese: 1 pinna mimlija għal-lest + 2 pads tal-alkoħol
English: MYLAN SAS 117 allée des Parcs 69800 SAINT PRIEST FRANCE
Maltese: SAS 117 allée des Parcs 69800 Saint Priest France
English: em., H-1036 Budapest Hungary
Maltese: H-1036 Budapest Hungary
English: 28108 Alcobendas (Madrid) Spain
Maltese: 28108 Alcobendas Madrid
English: Rua Quinta Pinheiro, 5, Outurela - Carnaxide
Maltese: Rua Quinta Pinheiro, 5, Outurela
English: Mylan BVBA/SPRL Terhulpsesteenweg 6A 1560 Hoeilaart Belgium
Maltese: Mylan BVBA/SPRL Terhulpsesteenweg 6A 1560
English: Osa Mayor, 4 28023 Aravaca (Madrid) Spain
Maltese: Osa Mayor, 4 28023 Aravaca Madrid
English: MAROUSSI GR-15125 ATHENS
Maltese: Athens GR-15125 Greece
English: Sandoz d.d Verovskova 57, 1000 Ljubljana
Maltese: Sandoz d.d Verovskova 57 1000 Ljubljana Slovenia
English: Ilford, Essex IG3 8BS
Maltese: Essex IG3 8BS
English: 13353 Berlin
Maltese: D-13353 Berlin
English: TEVA PHARMA, SLU Anabel Segura 11, Edificio Albatros B, 1ª planta 28108 Alcobendas (Madrid) Spain
Maltese: Teva Pharma, SLU Anabel Segura 11 Edificio Albatros B 1ª planta 28108 Alcobendas Madrid
English: 82031 Grünwald Germany
Maltese: 82031 Grünwald
English: LABORATOIRES MAJORELLE 80-82 rue Gallieni 92100 BOULOGNE BILLANCOURT FRANCE
Maltese: Laboratoires Majorelle 80-82 rue Gallieni 92100 Boulogne Billancourt
English: DE-89079 Ulm Germany
Maltese: DE-89079 Ulm
English: Berlifarma - Especialidades Farmaceuticas, Lda.
Maltese: BerlifarmaEspecialidades Farmaceuticas, Lda.
English: SANOFI AVENTIS FRANCE 1-13 BOULEVARD ROMAIN ROLLAND
Maltese: France 1-13 Boulevard Romain Rolland
English: United Kingdom Generics (UK) Limited, Station Close, Potters Bar, Hertfordshire EN6 1TL
Maltese: Generics (UK) Limited Station Close Potters Bar Hertfordshire EN6 1TL United Kingdom
English: Bayer S.p.A. Viale Certosa, 130 - 20156 Milano (MI) Italy
Maltese: Viale Certosa, 130 20156 Milano (MI) Italy
English: Comprimidos
Maltese: Tablets
English: Parc d'Activités des Peupliers - 25 rue des Peupliers 92000 NANTERRE FRANCE
Maltese: 25 rue des Peupliers 92000 Nanterre France
English: EG LABO - LABORATOIRES EUROGENERICS 12 rue Danjou le Quintet bâtiment A 92517 BOULOGNE BILLANCOURT CEDEX FRANCE
Maltese: LABORATOIRES EUROGENERICS 12 rue Danjou le Quintet bâtiment A 92517 Boulogne Billancourt Cedex France
English: Pliva Hungária Kereskedelmi és Szolgáltató Kft. Rákóczi út 70-72 Budapest 1074 Hungary
Maltese: Kft. Rákóczi út 70-72 Budapest 1074
English: Bayer Pharma
Maltese: Bayer Pharma AG
English: CYPROTERONE/ETHIN YLESTRADIOL BAYER 35 µg
Maltese: CYPROTERONE/ETHINYLESTRADIOL BAYER 35 µg
English: Sandoz GmbH Biochemiestrase 10 6250 Kundl Austria
Maltese: Sandoz GmbH Biochemiestrase 10 6250
English: Jan Emiel Mommaertslaan 14 1831 Machelen Belgium
Maltese: Mommaertslaan 14 1831 Machelen Belgium
English: Baix Llobregat 3 y 5 08970 Sant Joan Despi (Barcelona)
Maltese: 08970 Sant Joan Despi Barcelona
English: 220, avenue de la Recherche 59120 Loos
Maltese: Bayer Santé 220, avenue de la Recherche 59120 Loos France
English: Bayer Vital GmbH Kaiser-Wilhelm-Allee 51373 Leverkusen Germany
Maltese: Il-Ġermanja Bayer Vital GmbH Kaiser-Wilhelm-Allee 51373 Leverkusen Germany
English: ZYDUS France
Maltese: Puteaux France
English: United Kingdom Stragen UK Limited, Castle Court, 41 London Road,
Maltese: Stragen UK Limited Castle Court 41
English: Ratiopharm Arzneimittel Vertriebs-GmbH Albert-Schweitzer-Gasse 3 1140 Wien
Maltese: Ratiopharm Arzneimittel Vertriebs-GmbH Albert-Schweitzer-Gasse
English: EFFIK bâtiment ''le Newton'' 9-11 rue Jeanne Braconnier 92366 MEUDON LA FORET FRANCE
Maltese: EFFIK bâtiment ''le Newton'' 9-11 rue Jeanne Braconnier
English: Stragen Nordic A/S, Helsingørsgade 8C, DK-3400 Hillerød
Maltese: Stragen Nordic A/S Helsingørsgade 8C DK-3400
English: United Kingdom Bayer plc, Bayer House, strawberry Hill, Newbury, Berkshire RG14 1JA
Maltese: Strawberry Hill Newbury, Berkshire RG14 1JA,
English: Na Pankráci 14 14000 Praha 4 Czech Republic
Maltese: Na Pankráci 332/14 14000 Praha 4
English: United Kingdom Fannin (UK) Limited, 42-46 Booth Drive, Park Farm
Maltese: Ir-Renju Unit Fannin (UK) Limited 42-46 Booth Drive
English: United Kingdom Farmalider SA, Calle Aragoneses 15, Alcobendas, Madrid E-28108
Maltese: Farmalider SA Calle Aragoneses 15 Alcobendas Madrid E-28108 Spain
English: Poland acis Arzneimittel GmbH Lil-Dagover-Ring 7 82031 Grunwald Germany
Maltese: Acis Arzneimittel GmbH Lil-Dagover-Ring 7 82031 Grünwald Germany
English: Edvard Thomsens Vej 14, 2300 KØBENHAVN S, Denmark
Maltese: Edvard Thomsens Vej 14 DK-2300 København S Denmark
English: 92931 PARIS LA DEFENSE FRANCE
Maltese: 110 Esplanade du Général de Gaulle 92931 Paris la Defence France
English: Acnocin 2000/35 Tablets
Maltese: Acnocin 2000/35
English: Ratiopharm GmbH, GrafArco-Strasse 3
Maltese: Il-Ġermanja Ratiopharm GmbH Graf-Arco-Strasse 3
English: Diane 2000 micrograms/35 micrograms filmcoated tablets
Maltese: Diane 2000 micrograms/35 micrograms film-coated tablets
English: Pelpharma Handels GmbH Stammhausstraße 31 1140 Wien
Maltese: Stammhausstraße 31 1140
English: Reigate, Surrey RH2 9RJ
Maltese: Reigate, Surrey RH2 PRJ United Kingdom
English: LADEEPHARMA PHARMACEUTICAL Limited Lajos u. 48-66, E ép.
Maltese: Ir-Rumanija Ladeepharma Pharmaceutical Limited Lajos u.
English: Mithra Pharmaceuticals S.A. Rue Saint Georges 5 4000 Liège
Maltese: Rue Saint Georges 5 4000 Liège
English: Stragen UK Ltd.
Maltese: Medico Uno Worldwide Ltd.
English: Estonia ratiopharm GmbH Graf-Arco-Strasse 3 D-89079 Ulm Germany
Maltese: Ratiopharm GmbH Graf-Arco-Strasse 3 DE-89079 Ulm Germany
English: Heaton a.s.
Maltese: Heaton k.s.
English: Castle Court 41, London Road, Reigate, Surrey RH2 PRJ,
Maltese: London Road Reigate, Surrey RH2 PRJ United Kingdom
English: 3 DDD Pharma N.V. Diestersteenweg 349 3510 Hasselt Belgium
Maltese: Diestersteenweg 349 3510
English: BAYER ΕΛΛΑΣ ΑΒΕΕ SOROU 18-20
Maltese: Bayer Hellas ABEE Sorou 18-20
English: South, Wellingborough, Kent NN8 6GT
Maltese: Kent NN8 6GT
English: 21465 Reinbek Germany
Maltese: 61352 Bad Homburg Germany
English: SANDOZ A/S Edvard Thomsens Vej 14 2300 Copenhagen S Denmark
Maltese: Id-Danimarka Sandoz A/S Edvard Thomsens Vej 14 DK-2300 København S Denmark
English: Praga 10, Dolni Mecholupy
Maltese: Baix Llobregat 3 y
English: Fannin UK CoCyprindiol 2000/35 Tablets
Maltese: Fannin UK Co-Cyprindiol 2000/35
English: United Kingdom Teva UK Limited, Brampton Road, Hampden Park,
Maltese: Ir-Renju Unit Teva UK Limited Brampton Road